Lipid Nano-Sphere(LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV
References (5)
J.Pharm.Sci
(1985)- et al.
In Vivo Application of Lipoproteins as Drug Carriers
There are more references available in the full text version of this article.
Cited by (37)
Formulation development and characterization
2019, Engineering Drug Delivery SystemsThe properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization
2008, International Journal of PharmaceuticsDecreased binding affinity of apolipoprotein C-II to Lipid Nano-Sphere (LNS) plays an important role in the plasma half-life and reduced hƦmolytic activity
2004, Journal of Drug Delivery Science and TechnologyDecreased binding affinity of apolipoprotein E plays an important role in the reduced hepatic clearance of Lipid Nano-Sphere (LNS)
2004, Journal of Drug Delivery Science and TechnologyLipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins
2004, International Journal of PharmaceuticsA nanometer lipid emulsion, lipid nano-sphere (LNSĀ®), as a parenteral drug carrier for passive drug targeting
2004, International Journal of Pharmaceutics
Copyright Ā© 1994 Published by Elsevier B.V.